Hepatic Incidentalomas

Radiologic Clinics of North America

Volumn 49, Issue 2, 2011, Pages 291-322

  Gore, Richard M ^a   Newmark, Geraldine M ^a   Thakrar, Kiran H ^a   Mehta, Uday K ^a   Berlin, Jonathan W ^a  

^a NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

Author keywords

Bile duct hamartoma; Focal nodular hyperplasia; Hepatic adenoma; Hepatic cyst; Hepatic hemangioma; Incidentaloma; Liver CT; Liver metastases

Indexed keywords

ADENOCARCINOMA; ANATOMICAL VARIATION; ARTERIOVENOUS MALFORMATION; BILE DUCT HAMARTOMA; BILIARY ADENOCARCINOMA; CANCER PATIENT; CONTRAST ENHANCEMENT; CYSTADENOMA; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; FATTY LIVER; FIBROLAMELLAR CARCINOMA; HAMARTOMA; HEPATIC INCIDENTALOMA; HEPATIC LIPOMA; HUMAN; INCIDENCE; INCIDENTALOMA; INFERIOR CAVA VEIN; LIPOMA; LIVER ADENOMA; LIVER ARTERIOVENOUS MALFORMATION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER CYST; LIVER FOCAL NODULAR HYPERPLASIA; LIVER HEMANGIOMA; LIVER METASTASIS; LIVER NODULAR REGENERATIVE HYPERPLASIA; LIVER NODULE; LIVER POLYCYSTIC DISEASE; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY;

DIAGNOSTIC IMAGING; HUMANS; INCIDENTAL FINDINGS; LIVER DISEASES;

EID: 79951567147     PISSN: 00338389     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rcl.2010.10.004     Document Type: Review

References (143)

1. Feinstein E.G., Marr B.P., Winston C.B., et al. Hepatic abnormalities identified on abdominal computed tomography at diagnosis of uveal melanoma. Arch Ophthalmol 2010, 128:319-323.
2. Tsung A., Geller D.A. Workup of the incidental liver lesion. Adv Surg 2005, 39:331-341.
3. Ather M.H., Memon W., Rees J. Clinical impact of incidental diagnosis on non-contrast-enhanced helical CT for acute ureteral colic. Semin Ultrasound CT MR 2005, 26:20-23.
4. Green D.E., Woodward P.J. The management of indeterminate incidental findings detected at abdominal CT. Semin Ultrasound CT MR 2005, 26:2-13.
5. Khan K.Y., Xiong T., McCafferty I., et al. Frequency and impact of extracolonic findings detected at computed tomographic colonography in a symptomatic population. Br J Surg 2007, 94:355-361.
6. Sosna J., Kruskal J.B., Bar-Ziv J., et al. Extracolonic findings at CT colonography. Abdom Imaging 2005, 30:709-713.
7. Flicker M.S., Tsoukas A.T., Hazra A., et al. Economic impact of extracolonic findings at computed tomographic colonography. J Comput Assist Tomogr 2008, 32:497-503.
8. Gluecker T.M., Johnson C.D., Wilson L.A., et al. Extracolonic findings at CT colonography: evaluation of prevalence and cost in a screening population. Gastroenterology 2003, 124:911-916.
9. Pilch-Kowalczyk J., Konopka M., Bibinska J., et al. Extracolonic findings at CT colonography-additional advantages of the method. Med Sci Monit 2004, 10:22-25.
10. Hara A.K., Johnson C.D., MacCarty R.L., et al. Incidental findings at CT colonography. Radiology 2000, 215:353-357.
11. Hara A.K. Extracolonic findings at CT colonography. Semin Ultrasound CT MR 2005, 26:24-27.
12. Yee J., Kumar N.N., Godara S., et al. Extracolonic abnormalities discovered incidentally at CT colonography in a male population. Radiology 2005, 236:519-526.
13. Xiong T., Richardson M., Woodroffe R., et al. Incidental lesions found on CT colonography: their nature and frequency. Br J Radiol 2005, 78:22-29.
14. Spreng A., Netzer P., Mattich J., et al. Importance of extracolonic findings at IV contrast medium-enhanced CT colonography versus those at non-enhanced CT colonography. Eur Radiol 2005, 15:2088-2095.
15. Hellström M., Svensson M.H., Lasson A. Extracolonic and incidental findings on CT colonography (virtual colonoscopy). AJR Am J Roentgenol 2004, 182:631-638.
16. Salman R., Whiteley W.N., Warlow C. Screening using whole-body magnetic resonance imaging scanning: who wants an incidentaloma?. J Med Screen 2007, 14:2-4.
17. Gil B.N., Ran K., Tamar G., et al. Prevalence of significant noncardiac findings on coronary multidetector computed tomography angiography in asymptomatic patients. J Comput Assist Tomogr 2007, 31:1-4.
18. Pickhard P.J., Taylor A.J. Extracolonic findings identified in asymptomatic adults at screening colonoscopy. AJR Am J Roentgenol 2006, 186:718-728.
19. Seeff L.B., Everson G.T., Morgan T.R., et al. Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial. Clin Gastroenterol Hepatol 2010, 8:877-883.
20. Ros P.R., Erturk S.M. Benign tumors of the liver. Textbook of gastrointestinal radiology 2008, 1591-1622. Saunders, Philadelphia. R.M. Gore, M.S. Levine (Eds.).
21. Snover D.C. Non-neoplastic liver disease. Sternberg's diagnostic surgical pathology 2009, 1167-1191. Lippincott Williams & Wilkins, Philadelphia. 5th edition. E.C. Mills, D. Carter, J.K. Greeson (Eds.).
22. Washington K., Harris E. Masses of the liver. Sternberg's diagnostic surgical pathology 2009, 1192-2023. Lippincott Williams & Wilkins, Philadelphia. 5th edition. E.C. Mills, D. Carter, J.K. Greeson (Eds.).
23. Carrim Z.I., Murchison J.T. The prevalence of simple renal and hepatic cysts detected by spiral computed tomography. Clin Radiol 2003, 58:626-629.
24. Oto A., Tamm E.P., Zklaruk J. Multidetector row CT of the liver. Radiol Clin North Am 2005, 43:827-848.
25. Rumack C.M., Wilson S.R., Charboneau W. The liver. Diagnostic ultrasound 2005, 678-801. Mosby, Philadelphia. 3rd edition.
26. Braga L., Armao D., Semelka R.C. Liver. Abdominal-pelvic MRI 2010, 347-446. John Wiley, Hoboken (NJ). 3rd edition. R.C. Semelka (Ed.).
27. Mortele K., Peters H.E. Multimodality imaging of common and uncommon cystic focal liver lesions. Semin Ultrasound CT MR 2009, 30:368-386.
28. Cavallari A. Bile duct hamartomas: diagnostic problems and treatment. Hepatogastroenterology 1997, 44:994-997.
29. Anderson S.W., Kruskal J.B., Kane R.A. Benign hepatic tumors and iatrogenic pseudotumors. Radiographics 2009, 29:211-229.
30. Brancatelli G., Federle M.P., Vilgrain V., et al. Fibropolycystic liver disease: CT and MR imaging findings. Radiographics 2005, 25:659-670.
31. Lev-Toaff A.S., Bach A.M., Wechsler R.J., et al. The radiologic and pathologic spectrum of biliary hamartomas. AJR Am J Roentgenol 1995, 165:309-313.
32. Cheung Y.C., Tan C.F., Wan Y.L., et al. MRI of multiple biliary hamartomas. Br J Radiol 1997, 70:527-529.
33. Mortele B., Mortele K., Seynaeve P., et al. Hepatic bile duct hamartomas (von Meyenburg complexes): MR and MR cholangiography findings. J Comput Assist Tomogr 2002, 26:438-443.
34. Slone H.W., Bennett W.F., Bova J.G. MR findings of multiple biliary hamartomas. AJR Am J Roentgenol 1993, 161:581-583.
35. Choi B.I., Lee J.M. Neoplasms of the gallbladder and biliary tract. Textbook of gastrointestinal radiology 2008, 1467-1488. Saunders, Philadelphia. 3rd edition. R.M. Gore, M.S. Levine (Eds.).
36. Choi H.K., Lee J.K., Lee K.H., et al. Differential diagnosis for intrahepatic biliary cystadenoma and hepatic simple cyst: significance of cystic fluid analysis and radiologic findings. J Clin Gastroenterol 2010, 44:289-293.
37. Mortelé K.J., Ros P.R. Cystic focal liver lesions in the adult: differential CT and MR imaging features. Radiographics 2001, 21:895-910.
38. Tiniakos D.G., Vos M.B., Brunt E.M. Nonalcoholic fatty liver disease: pathology and pathogenesis. Annu Rev Pathol 2010, 5:145-171.
39. Gore R.M. Diffuse liver disease. Textbook of gastrointestinal radiology 2008, 1685-1730. Saunders, Philadelphia. 3rd edition. R.M. Gore, M.S. Levine (Eds.).
40. Hamer O.W., Aguirre D.A., Casola G., et al. Fatty liver: imaging patterns and pitfalls. Radiographics 2006, 26:1637-1653.
41. Tamai H., Shingaki N., Oka M., et al. Multifocal nodular fatty infiltration of the liver mimicking metastatic liver tumors. J Ultrasound Med 2006, 25:403-406.
42. Browning J.D. New imaging techniques for non-alcoholic steatohepatitis. Clin Liver Dis 2009, 13:607-619.
43. Desser T.S. Understanding transient hepatic attenuation differences. Semin Ultrasound CT MR 2009, 30:408-417.
44. Goshima S., Kanematsu M., Watanabe H., et al. Hepatic hemangioma and metastasis: differentiation with gadoxetate disodium-enhanced 3-T MRI. AJR Am J Roentgenol 2010, 195:941-946.
45. Jang H.-J., Kim T.K., Lim H.K. Hepatic hemangioma: atypical appearances on CT, MR imaging, and sonography. AJR Am J Roentgenol 2003, 180:135-141.
46. Ma X., Holalkere N.S., Kambadakone R.A., et al. Imaging-based quantification of hepatic fat: methods and clinical applications. Radiographics 2009, 29:1253-1277.
47. Miyake H., Suzuki K., Ueda S., et al. Localized fat collection adjacent to the intrahepatic portion of the inferior vena cava: a normal variant on CT. AJR Am J Roentgenol 1992, 158:423-425.
48. Perry J.N., Williams M.P., Dubbins P.A., et al. Lipomata of the inferior vena cava: a normal variant?. Clin Radiol 1994, 49:341-342.
49. Han B.K., Im J.G., Jung J.W., et al. Pericaval fat collection that mimics thrombosis of the inferior vena cava: demonstration with use of multi-directional reformation CT. Radiology 1997, 203:105-108.
50. Hines J., Katz D.S., Goffner L., et al. Fat collection related to the intrahepatic inferior vena cava on CT. AJR Am J Roentgenol 1999, 172:409-411.
51. Baba Y., Hokotate H., Inoue H., et al. Pericaval fat mimicking intracaval deposits on unenhanced and contrast-enhanced helical CT in patients with cirrhosis. J Comput Assist Tomogr 2001, 25:851-855.
52. Bioulac-Sage P., Laumonier H., Laurent C., et al. Benign and malignant vascular tumors of the liver in adults. Semin Liver Dis 2008, 28:302-314.
53. Kamaya A., Maturen K.E., Tye G.A., et al. Hypervascular liver lesions. Semin Ultrasound CT MR 2009, 30:387-407.
54. Arbiser J.L., Bonner M.Y., Berrios R.L. Hemangiomas, angiosarcomas, and vascular malformations represent the signaling abnormalities of pathogenic angiogenesis. Curr Mol Med 2009, 9:929-934.
55. Dietrich C.F., Mertens J.C., Braden B., et al. Contrast-enhanced ultrasound of histologically proven liver hemangiomas. J Hepatol 2007, 45:1139-1145.
56. Kim K.W., Kim A.Y., Kim T.K., et al. Hepatic hemangiomas with arterioportal shunt: sonographic appearances with CT and MRI correlation. AJR Am J Roentgenol 2006, 187:W406-W414.
57. Kobayashi S., Maruyama H., Okugawa H., et al. Contrast-enhanced US with levovist for the diagnosis of hepatic hemangioma: time-related changes of enhancement appearance and the hemodynamic background. Hepatogastroenterology 2008, 55:1222-1228.
58. Yamashita Y., Ogata I., Urata J., et al. Cavernous hemangioma of the liver: pathologic correlation with dynamic CT findings. Radiology 1997, 203:121-125.
59. Silva A.C., Evans J.M., McCullough A.E., et al. MR imaging of hypervascular liver masses: a review of current techniques. Radiographics 2009, 29:385-402.
60. Nguyen B.N., Flejou J.F., Terris B., et al. Focal nodular hyperplasia of the liver: a comprehensive pathologic study of 305 lesions and recognition of new histologic forms. Am J Surg Pathol 1999, 23:1441-1454.
61. Vilgrain V. Focal nodular hyperplasia. Eur J Radiol 2006, 58:236-245.
62. Cherqui D., Rahmouni A., Charlotte F., et al. Management of focal nodular hyperplasia and hepatocellular adenoma in young women: a series of 41 patients with clinical, radiological, and pathological correlations. J Hepatol 1995, 22:1674-1681.
63. Kim M.J., Lim H.K., Kim S.H., et al. Evaluation of hepatic focal nodular hyperplasia with contrast-enhanced gray scale harmonic sonography: initial experience. J Ultrasound Med 2004, 23:297-305.
64. van den Esschert J.W., van Gulik T.M., Phoa S.S. Imaging modalities for focal nodular hyperplasia and hepatocellular adenoma. Dig Surg 2010, 27:46-55.
65. Hussain S.M., Terkivatan T., Zondervan P.E., et al. Focal nodular hyperplasia: findings at state-of-the-art MR imaging, US, CT, and pathologic analysis. Radiographics 2004, 24:3-17.
66. Kehagias D., Moulopoulos L., Antoniou A., et al. Focal nodular hyperplasia: imaging findings. Eur Radiol 2001, 11:202-212.
67. Brancatelli G., Federle M.P., Grazioli L., et al. Focal nodular hyperplasia: CT findings with emphasis on multiphasic helical CT in 78 patients. Radiology 2001, 219:61-68.
68. Lin M.C., Tsay P.K., Ko S.F., et al. Triphasic dynamic CT findings of 63 hepatic focal nodular hyperplasia in 46 patients: correlation with size and pathological findings. Abdom Imaging 2008, 33:301-307.
69. Shirkhoda A., Farah M.C., Bernacki E., et al. Hepatic focal nodular hyperplasia: CT and sonographic spectrum. Abdom Imaging 1994, 19:34-38.
70. Caseiro-Alves F., Zins M., Mahfouz A.E., et al. Calcification in focal nodular hyperplasia: a new problem for differentiation from fibrolamellar hepatocellular carcinoma. Radiology 1996, 198:889-892.
71. Choi C.S., Freeny P.C. Triphasic helical CT of hepatic focal nodular hyperplasia: incidence of atypical findings. AJR Am J Roentgenol 1998, 170:391-395.
72. Carlson S.K., Johnson C.D., Bender C.E., et al. Of focal nodular hyperplasia of the liver. AJR Am J Roentgenol 2000, 174:705-712.
73. Mortele K.J., Praet M., Van Vlierberghe H., et al. CT and MR imaging findings in focal nodular hyperplasia of the liver: radiologic-pathologic correlation. AJR Am J Roentgenol 2000, 175:687-692.
74. Grazioli L., Morana G., Kirchin M.A., et al. Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study. Radiology 2005, 236:166-177.
75. Ba-Ssalamah A., Schima W., Schmook M.T., et al. Atypical focal nodular hyperplasia of the liver: imaging features of nonspecific and liver-specific MR contrast agents. AJR Am J Roentgenol 2002, 179:1447-1456.
76. Kobayashi S., Matsui O., Gabata T., et al. Radiological and histopathological manifestations of hepatocellular nodular lesions concomitant with various congenital and acquired hepatic hemodynamic abnormalities. Jpn J Radiol 2009, 27:53-68.
77. Golli M., Van Nhieu J.T., Mathieu D., et al. Hepatocellular adenoma: color Doppler US and pathologic correlations. Radiology 1994, 190:741-744.
78. Hussain S.M., van den Bos I.C., Dwarkasing R.S., et al. Hepatocellular adenoma: findings at state-of-the-art magnetic resonance imaging, ultrasound, computed tomography and pathologic analysis. Eur Radiol 2006, 16:1873-1886.
79. Ichikawa T., Federle M.P., Grazioli L., et al. Hepatocellular adenoma: multiphasic CT and histopathologic findings in 25 patients. Radiology 2000, 214:861-868.
80. Arrive L., Flejou J.F., Vilgrain V., et al. Hepatic adenoma: MR findings in 51 pathologically proved lesions. Radiology 1994, 193:507-512.
81. Brancatelli G., Federle M.P., Vullierme M.P., et al. CT and MR imaging evaluation of hepatic adenoma. J Comput Assist Tomogr 2006, 30:745-750.
82. Al-Mukhaizeem K.A., Rosenberg A., Sherker A.H. Nodular regenerative hyperplasia of the liver: an under-recognized cause of portal hypertension in hematological disorders. Am J Hematol 2004, 75:225-330.
83. Dachman A.H., Ros P.R., Goodman Z.D., et al. Nodular regenerative hyperplasia of the liver: clinical and radiologic observations. AJR Am J Roentgenol 1987, 148:717-722.
84. Siegelman E.S., Outwater E.K., Furth E.E., et al. MR imaging of hepatic nodular regenerative hyperplasia. J Magn Reson Imaging 1995, 5:730-732.
85. Ros P.R., Taylor H.M. Malignant tumors of the liver. Textbook of gastrointestinal radiology 2000, 1523-1568. WB Saunders, Philadelphia. R.M. Gore, M.S. Levine (Eds.).
86. Shariff M.I., Cox I.J., Gomaa A.I., et al. Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics. Expert Rev Gastroenterol Hepatol 2009, 3:353-367.
87. Schütte K., Bornschein J., Malfertheiner P. Hepatocellular carcinoma-epidemiological trends and risk factors. Dig Dis 2009, 27:80-92.
88. Altekruse S.F., McGlynn K.A., Reichman M.E. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 2009, 20(27):1485-1491.
89. Ahmed F., Perz J.F., Kwong S., et al. National trends and disparities in the incidence of hepatocellular carcinoma, 1998-2003. Prev Chronic Dis 2008, 5:74-82.
90. Liu G.J., Wang W., Xie X.Y., et al. Real-time contrast-enhanced ultrasound imaging of focal liver lesions in fatty liver. Clin Imaging 2010, 34:v211-v221.
91. Lee M.W., Kim Y.J., Park H.S., et al. Targeted sonography for small hepatocellular carcinoma discovered by CT or MRI: factors affecting sonographic detection. AJR Am J Roentgenol 2010, 194:W396-W400.
92. Colli A., Fraquelli M., Casazza G., et al. Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review. Am J Gastroenterol 2006, 101:513-523.
93. Baron R.L., Brancatelli G. Computed tomographic imaging of hepatocellular carcinoma. Gastroenterology 2004, 127(Suppl 1):S133-S143.
94. Laghi A., Iannaccone R., Rossi P., et al. Hepatocellular carcinoma: detection with triple-phase multi-detector row helical CT in patients with chronic hepatitis. Radiology 2003, 226:543-549.
95. Mitsuzaki K., Yamashita Y., Ogata I., et al. Multiple-phase helical CT of the liver for detecting small hepatomas in patients with liver cirrhosis: contrast-injection protocol and optimal timing. AJR Am J Roentgenol 1996, 167:753-757.
96. Monzawa S., Ichikawa T., Nakajima H., et al. Dynamic CT for detecting small hepatocellular carcinoma: usefulness of delayed phase imaging. AJR Am J Roentgenol 2007, 188:147-153.
97. Willatt J.M., Hussain H.K., Adusumilli S., et al. MR imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies. Radiology 2008, 247:311-330.
98. Cabibbo G., Craxì A. Epidemiology, risk factors and surveillance of hepatocellular carcinoma. Eur Rev Med Pharmacol Sci 2010, 14:352-355.
99. Wong L.K., Link D.P., Frey C.F., et al. Fibrolamellar hepatocarcinoma: radiology, management, and pathology. AJR Am J Roentgenol 1982, 139:172-175.
100. Smith M.T., Blatt E.R., Jedlicka P., et al. Best cases from the AFIP: fibrolamellar hepatocellular carcinoma. Radiographics 2008, 28:609-613.
101. McLarney J.K., Rucker P.T., Bender G.N., et al. Fibrolamellar carcinoma of the liver: radiologic-pathologic correlation. Radiographics 1999, 19:453-471.
102. Terzis I., Haritanti A., Economou I. Fibrolamellar hepatocellular carcinoma: a case report with distinct radiological features. J Gastrointest Cancer 2010, 41:2-5.
103. Bedi D.G., Kumar R., Morettin L.B., et al. Fibrolamellar carcinoma of the liver: CT, ultrasound and angiography. Eur J Radiol 1988, 8:109-112.
104. Abrams H.L., Giordano T.J., Brodeur F.J., et al. Metastases in carcinoma: analysis of 1000 autopsied cases. Cancer 1950, 3:74-85.
105. Primrose J.N. Surgery for colorectal liver metastases. Br J Cancer 2010, 102:1313-1318.
106. Namasivayam S., Martin D.R., Saini S. Imaging of liver metastases: MRI. Cancer Imaging 2007, 7:2-9.
107. Ahn J.H., Yu J.S., Hwang S.H., et al. Nontumorous arterioportal shunts in the liver: CT and MRI findings considering mechanisms and fate. Eur Radiol 2010, 20:385-394.
108. Colegrande S., Centi N., Galdiero R., et al. Transient hepatic intensity differences: part 1. Those associated with focal lesions. AJR Am J Roentgenol 2007, 188:154-159.
109. Colegrande S., Centi N., Galdiero R., et al. Transient hepatic intensity differences: part 2. Those not associated with focal lesions. AJR Am J Roentgenol 2007, 188:160-166.
110. Eberhardt S.C., Choi P.H., Bach A.M., et al. Utility of sonography for small hepatic lesions found on computed tomography in patients with cancer. J Ultrasound Med 2003, 22:335-343.
111. Kim H.J., Kim A.Y., Kim T.K., et al. Transient hepatic attenuation differences in focal hepatic lesions: dynamic CT features. AJR Am J Roentgenol 2005, 184:83-90.
112. Colegrande S., Centi N., La Villa G., et al. Transient hepatic attenuation differences. AJR Am J Roentgenol 2004, 183:459-464.
113. Lee K.H., Han J.K., Jeong J.Y., et al. Hepatic attenuation differences associated with obstruction of the portal or hepatic veins in patients with hepatic abscesses. AJR Am J Roentgenol 2005, 185:1015-1023.
114. Choi S.H., Lee J.M., Lee K.H., et al. Relationship between various patterns of transient hepatic attenuation on CT and portal vein thrombosis related to acute cholecystitis. AJR Am J Roentgenol 2004, 183:437-442.
115. Yoshimoto K., Honda H., Kuriowa T., et al. Unusual hemodynamics and pseudolesions of the noncirrhotic liver at CT. Radiographics 2001, 881-896.
116. Quiroag S., Sebastia C., Pallisa E., et al. Improved diagnosis of hepatic perfusion disorders: value of hepatic arterial phase imaging during helical CT. Radiographics 2001, 21:65-81.
117. Colagrande S., Centi N., Pradella S., et al. Transient hepatic attenuation differences and focal liver lesions: sump effect due to primary arterial hyperperfusion. J Comput Assist Tomogr 2009, 33:259-265.
118. Yamasaki M., Furukawa A., Murata K., et al. Transient hepatic attenuation difference (THAD) in patients without neoplasm: frequency, shape, distribution, and causes. Radiat Med 1999, 17(2):91-96.
119. Ito K., Awaya H., Mitchell D.G., et al. Gallbladder disease: appearance of associated transient increased attenuation in the liver at biphasic, contrast-enhanced dynamic CT. Radiology 1997, 204:723-728.
120. Chen W.P., Chen J.H., Hwang J.I., et al. Spectrum of transient hepatic attenuation differences in biphasic helical CT. AJR Am J Roentgenol 1999, 172:419-424.
121. Catalano O., Sandomenico F., Nunziata A., et al. Transient hepatic echogenicity difference on contrast-enhanced ultrasonography: sonographic sign and pitfall. J Ultrasound Med 2007, 26:337-345.
122. Hwang S.H., Yu J.S., Chung J., et al. Transient hepatic attenuation difference (THAD) following transcatheter arterial chemoembolization for hepatic malignancy: changes on serial CT examinations. Eur Radiol 2008, 18(1):596-603.
123. Yamashita K., Jin M.J., Hirose Y., et al. CT finding of transient focal increased attenuation of the liver adjacent to the gallbladder in acute cholecystitis. AJR Am J Roentgenol 1995, 164:343-346.
124. Tian J.L., Zhang J.S. Hepatic perfusion disorders: etiopathogenesis and related diseases. World J Gastroenterol 2006, 12:3265-3270.
125. Gabata T., Kadoya M., Matsui O., et al. Dynamic CT of hepatic abscesses: significance of transient segmental enhancement. AJR Am J Roentgenol 2001, 176:675-679.
126. Pradella S., Centi N., La Villa G., et al. Transient hepatic attenuation difference (THAD) in biliary duct disease. Abdom Imaging 2009, 34:626-633.
127. Soyer P., Devine N., Somveille E., et al. Hepatic pseudolesion around the falciform ligament: prevalence on CT examination. Abdom Imaging 1996, 21:324-328.
128. Yoshimitsu K., Honda H., Kuroiwa T., et al. Pseudolesions of the liver possibly caused by focal rib compression: analysis based on hemodynamic change. AJR Am J Roentgenol 1999, 172:645-649.
129. Bertolotto M., Martinoli C., Migaleddu V., et al. Color Doppler sonography of intrahepatic vascular shunts. J Clin Ultrasound 2008, 36:527-538.
130. Khalid S.K., Garcia-Tsao G. Hepatic vascular malformations in hereditary hemorrhagic telangiectasia. Semin Liver Dis 2008, 28:247-258.
131. Danet I.M., Semelka R.C., Leonardou P., et al. Spectrum of MRI appearances of untreated metastases of the liver. AJR Am J Roentgenol 2003, 181:809-817.
132. Sica G.T., Ji H., Ros P.R. CT and MR imaging of hepatic metastases. AJR Am J Roentgenol 2000, 174:691-698.
133. Holalkere N.-J., Sahani D.V., Blake M.A., et al. Characterization of small liver lesions: added role of MR after MDCT. J Comput Assist Tomogr 2006, 30:591-596.
134. Lim G.H., Koh D.C., Cheong W.K., et al. Natural history of small, " indeterminate" hepatic lesions in patients with colorectal cancer. Dis Colon Rectum 2009, 52:1487-1491.
135. Patterson S.A., Khalil H.I., Panicek D.M. MRI evaluation of small hepatic lesions in women with breast cancer. AJR Am J Roentgenol 2006, 187:307-312.
136. Jones E.C., Chezmar J.L., Nelson R.C., et al. The frequency and significance of small (less than or equal to 15 mm) hepatic lesions detected by CT. AJR Am J Roentgenol 1992, 158:535-539.
137. Schwartz L.H., Gandras E.J., Colangelo S., et al. Prevalence and importance of small hepatic lesions found at CT in patients with cancer. Radiology 1999, 210:71-74.
138. Jang H.J., Lim H.K., Lee W.J., et al. Small hypoattenuating lesions in the liver on single-phase helical CT in preoperative patients with gastric and colorectal cancer: prevalence, significance, and differentiating features. J Comput Assist Tomogr 2002, 26:718-724.
139. Khalil H.I., Patterson S.A., Panicek D.M. Hepatic lesions deemed too small to characterize at CT: prevalence and importance in women with breast cancer. Radiology 2005, 235:872-878.
140. Krakora G.A., Coakley F.V., Williams G., et al. Small hypoattenuating hepatic lesions at contrast-enhanced CT: prognostic importance in patients with breast cancer. Radiology 2004, 233:667-673.
141. Hwang S.H., Yu J.S., Kim K.W., et al. Small hypervascular enhancing lesions on arterial phase images of multiphase dynamic computed tomography in cirrhotic liver: fate and implications. J Comput Assist Tomogr 2008, 32:39-45.
142. Holland A.E., Hecht E.M., Hahn W.Y., et al. Importance of small (≤20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: evaluation and comparison with whole explanted liver. Radiology 2005, 237:938-944.
143. Berland L.L., Silverman S.G., Gore R.M., et al. Managing incidental findings on abdominal CT: white paper of the ACR Incidental Finding Committee. J Am Coll Radiol 2010, 7:754-773.